New medical research is revealing significant findings in the treatment of concussions that involves cannabis. A joint project by the University of Miami Miller School of Medicine, Toronto’s Scythian Biosciences Corp., and The Miami Project to Cure Paralysis has led to the development of a “concussion pill,” which combines CBD and an NMDA amino acid anesthetic, according to UPI. Pre-clinical studies on rodents are showing improved cognitive function after traumatic brain injury, more so than either component of the pills does on its own. Trials also showed no adverse effects caused by either component individually nor in combination.
Traumatic brain injuries have made headlines in recent years as more attention has been brought to the dangers of aggressive contact sports, such as football, and the long-term damage caused by concussions. Meanwhile, football players have become some of the strongest advocates for medical marijuana. Cannabis, particularly CBD, has proven to be effective at treating chronic pain caused by sport-related injuries, and does not have the addictive properties of opioids, which are typically prescribed for such injuries. Other players suffer from conditions unrelated to sports, but using medical marijuana has made it possible for them to enjoy activities with fewer limitations. For example, medical marijuana is proving to be a breakthrough treatment for severe seizures, paving the way for people with epilepsy to perform at a competitive level like never before. All of these factors make athletes ideal for receiving the benefits of medical marijuana treatments. Yet continued backward thinking about the drug is holding us back.